Get 40% Off
Is NVDA a 🟢 buy or 🔴 sell?Unlock Now

Immunitybio Inc (IBRX)

NASDAQ
Currency in USD
Disclaimer
3.50
-1.74(-33.21%)
Closed
After Hours
3.78+0.28(+8.00%)
Unusual Post-Market activity
Day's Range
3.375.21
52 wk Range
1.216.93
Prev. Close
5.24
Open
5.19
Day's Range
3.37-5.21
52 wk Range
1.21-6.93
Volume
15,310,460
Average Vol. (3m)
3,965,940
1-Year Change
35.14%
Shares Outstanding
670,331,089
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
4.00
Upside +14.29%

People Also Watch

13.32
TGTX
-0.89%
32.31
GCT
-7.45%
860.01
SMCI
-11.84%
9.60
NKTX
+1.05%
0.682
AGEN
+1.05%
How do you feel today about IBRX?
Vote to see community's results!
or
  • 5 Stocks With Strong Upward Momentum
  • 6 Stocks That Could Shoot Higher
  • 7 Stocks That Could Jump Higher

Immunitybio Inc Company Profile

Immunitybio, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing therapies and vaccines that improve the immune system to defeat cancers and infectious diseases. Its segment is focused on creating the next generation of immunotherapies to address serious unmet needs within oncology and infectious diseases. Its platforms include antibody cytokine fusion proteins; DNA, RNA, and recombinant protein vaccine technologies, including self-amplifying RNA, second-generation adenovirus hAd5 vector and recombinant protein platforms; toll-like receptor activating adjuvants; natural killer (NK) cell therapy, including off-the-shelf NK cells, and autologous and allogenic memory-like cytokine-enhanced NK cells (M-ceNK); damage-associated molecular patterns inducers, including Aldoxorubicin and Nanatinostat. Its clinical pipeline consists of over 26 clinical trials of which 17 are in Phase I or III development, across 13 indications in liquid and solid tumors.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.